Published in Psychopharmacology (Berl) on July 13, 2004
Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease. Neurosci Biobehav Rev (2008) 1.65
How to increase serotonin in the human brain without drugs. J Psychiatry Neurosci (2007) 1.27
Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome. Eur Arch Psychiatry Clin Neurosci (2009) 1.06
Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. BMC Neurol (2010) 1.00
The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatr Clin North Am (2009) 1.00
Forebrain GABAergic projections from the dorsal raphe nucleus identified by using GAD67-GFP knock-in mice. J Comp Neurol (2012) 0.98
Prenatal depression effects and interventions: a review. Infant Behav Dev (2010) 0.96
Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile. Sci Rep (2012) 0.95
Effects of Sumsu (Bufonis venenum) Pharmacopuncture Treatment on Depression in Mice. J Pharmacopuncture (2014) 0.88
Real-time, spatially resolved analysis of serotonin transporter activity and regulation using the fluorescent substrate, ASP+. J Neurochem (2010) 0.86
Enlarged thalamic volumes and increased fractional anisotropy in the thalamic radiations in veterans with suicide behaviors. Front Psychiatry (2013) 0.81
Effects of acute tryptophan depletion on affective processing in first-degree relatives of depressive patients and controls after exposure to uncontrollable stress. Psychopharmacology (Berl) (2008) 0.81
Differential effects of 5-HTTLPR genotypes on mood, memory, and attention bias following acute tryptophan depletion and stress exposure. Psychopharmacology (Berl) (2008) 0.80
Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond. Eur Arch Psychiatry Clin Neurosci (2008) 0.80
Gene-environment interactions in geriatric depression. Psychiatr Clin North Am (2011) 0.79
The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat. Psychopharmacology (Berl) (2008) 0.79
Serotonin transporter gene as a predictor of stress generation in depression. J Abnorm Psychol (2012) 0.78
5HTTLPR predicts left fusiform gyrus activation to positive emotional stimuli. Magn Reson Imaging (2008) 0.78
Combination/augmentation strategies for improving the treatment of depression. Neuropsychiatr Dis Treat (2005) 0.77
Prenatal serotonin and neonatal outcome: brief report. Infant Behav Dev (2008) 0.76
Chronic administration of 13-cis-retinoic acid does not alter the number of serotoninergic neurons in the mouse raphe nuclei. Neuroscience (2010) 0.75
The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition. Eur Arch Psychiatry Clin Neurosci (2008) 0.75
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (2003) 28.61
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
Serotonin transporter genetic variation and the response of the human amygdala. Science (2002) 9.31
The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry (2001) 7.80
Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08
A review of central 5-HT receptors and their function. Neuropharmacology (1999) 6.13
Genomic medicine--a primer. N Engl J Med (2002) 4.77
Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature (2002) 3.92
The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci (2003) 3.79
The cellular neurobiology of depression. Nat Med (2001) 3.19
Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry (1998) 3.07
The Tridimensional Personality Questionnaire: U.S. normative data. Psychol Rep (1991) 3.06
Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci U S A (1993) 2.80
Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem (1994) 2.77
Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology (2003) 2.75
Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci (2003) 2.67
Relapse of depression after rapid depletion of tryptophan. Lancet (1997) 2.61
A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry (1996) 2.60
Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci U S A (1998) 2.54
A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry (2000) 2.50
PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry (1999) 2.48
A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry (2000) 2.32
Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci U S A (1998) 2.27
Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry (2000) 2.25
The ETS domain factor Pet-1 is an early and precise marker of central serotonin neurons and interacts with a conserved element in serotonergic genes. J Neurosci (1999) 2.17
Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet (1999) 2.16
Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry (2003) 2.13
Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry (1998) 2.03
Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. Am J Psychiatry (2004) 2.00
Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care (2004) 1.97
Organization of the human serotonin transporter gene. J Neural Transm Gen Sect (1994) 1.97
Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry (2004) 1.92
Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry (1997) 1.71
Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry (2003) 1.71
Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. Am J Psychiatry (2002) 1.70
Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci (2004) 1.61
Mood disorders and medical illness: a major public health problem. Biol Psychiatry (2003) 1.56
The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology (Berl) (2002) 1.56
Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide. Mol Psychiatry (2000) 1.51
Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology (1998) 1.51
Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry (1998) 1.48
Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. Am J Psychiatry (2001) 1.47
Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology (2000) 1.45
Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry (2004) 1.45
No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse (2003) 1.44
Serotonin transporter gene polymorphism and antidepressant response. Neuroreport (2000) 1.42
Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology (2004) 1.41
The human serotonin transporter gene polymorphism--basic research and clinical implications. J Neural Transm (Vienna) (1997) 1.39
The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1. J Biol Chem (1996) 1.37
Total and free tryptophan concentration in the plasma of depressive patients. Lancet (1973) 1.34
Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci (1986) 1.31
Freud-1: A neuronal calcium-regulated repressor of the 5-HT1A receptor gene. J Neurosci (2003) 1.28
"Serotonin depression"--a biochemical subgroup within the affective disorders? Science (1976) 1.24
Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry (2002) 1.24
Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry (1994) 1.24
Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology (1996) 1.23
Genome-based pharmacogenetics and the pharmaceutical industry. Nat Rev Drug Discov (2002) 1.22
Serotonin receptors in the human brain--III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience (1987) 1.22
Tryptophan depletion, serotonin, and depression: where do we stand? Psychopharmacol Bull (2003) 1.19
Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology (1988) 1.19
Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J Clin Psychopharmacol (2000) 1.17
Role of the serotonin transporter promoter polymorphism in anxiety-related traits. Arch Gen Psychiatry (1998) 1.16
Genetic inactivation of the Serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety. J Neurosci (2000) 1.16
Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry (2002) 1.13
Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. Brain Res (1990) 1.12
Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications. Endocrinol Metab Clin North Am (2002) 1.10
A common C-1018G polymorphism in the human 5-HT1A receptor gene. Psychiatr Genet (1999) 1.09
Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet (2000) 1.08
Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders. Genes Brain Behav (2003) 1.05
Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Mol Psychiatry (1998) 1.05
Decreased plasma tryptophan levels in major depression. J Affect Disord (1989) 1.04
A quantitative autoradiographic study of serotonin1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology (1991) 1.04
Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett (2001) 1.01
Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. Neuropsychopharmacology (1999) 1.01
High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography. Arch Gen Psychiatry (2003) 1.01
A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Mol Psychiatry (1998) 1.00
No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism. Biol Psychiatry (2001) 0.99
Novel dual repressor elements for neuronal cell-specific transcription of the rat 5-HT1A receptor gene. J Biol Chem (2000) 0.99
Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment. Synapse (1989) 0.97
Maternal effects in infant and adult phenotypes of 5HT1A and 5HT1B receptor knockout mice. Dev Psychobiol (2003) 0.94
5-HT1A receptor knockout mouse as a genetic model of anxiety. Eur J Pharmacol (2003) 0.94
5-HT1A receptor and 5-HT1B receptor knockout mice in stress and anxiety paradigms. Behav Pharmacol (2003) 0.93
Autoradiographic analyses of the effects of restraint-induced stress on 5-HT1A, 5-HT1C and 5-HT2 receptors in the dorsal hippocampus of male and female rats. Neuroendocrinology (1991) 0.93
Tryptophan depletion and depressive vulnerability. Biol Psychiatry (1999) 0.93
Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system. J Clin Psychiatry (1991) 0.93
A role for the mineralocorticoid receptor in a rapid and transient suppression of hippocampal 5-HT1A receptor mRNA by corticosterone. J Neuroendocrinol (1995) 0.93
Corticosterone suppresses the expression of 5-HT1A receptor mRNA in rat dentate gyrus. Eur J Pharmacol (1994) 0.93
Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacology (1995) 0.92
Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse. J Pharmacol Exp Ther (2001) 0.92
Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence. Alcohol Clin Exp Res (1997) 0.92
Elevated basal trough levels of corticosterone suppress hippocampal 5-hydroxytryptamine(1A) receptor expression in adrenally intact rats: implication for the pathogenesis of depression. Neuroscience (1997) 0.92
[11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats. Synapse (2003) 0.92
Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders. Biol Psychiatry (1999) 0.91
5-HT(1A) receptor mutant mice exhibit enhanced tonic, stress-induced and fluoxetine-induced serotonergic neurotransmission. J Neurochem (2001) 0.91
An association study of a functional polymorphism of the serotonin transporter gene with personality and psychiatric symptoms. Mol Psychiatry (1998) 0.91
Clinical and neurochemical effect of acute tryptophan depletion in unaffected relatives of patients with bipolar affective disorder. Biol Psychiatry (2001) 0.91
No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance. Mol Psychiatry (1997) 0.91
Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter. Neuropharmacology (1994) 0.90
Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism. Mol Psychiatry (1999) 0.90
Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease. Neuroreport (1997) 0.89
Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects. Biol Psychiatry (2005) 1.51
Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry (2002) 1.24
beta2 Nicotinic acetylcholine receptor availability in post-traumatic stress disorder. Int J Neuropsychopharmacol (2008) 0.77